Global Lugol's Iodine Market Growth 2025-2031
The global Lugol's Iodine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
Lugol's iodine, also known as Lugol's solution, first made in 1829, is a solution of iodine named after the French physician J.G.A. Lugol. Lugol's iodine solution is often used as an antiseptic and disinfectant, a starch indicator, to replenish iodine deficiency, to protect the thyroid gland from radioactive materials (e.g. "fallout"), and for emergency disinfection of drinking water. Lugol's was often used in the treatment of gout and was used as a first line treatment for hypothyroidism in adults.
Segmentation by Type:
- Lugol's Iodine for Microscopy
- Lugol's Iodine for the Gram Staining Method
- Others
Segmentation by Application:
- Laboratory
- Hospital
- Clinic
- Others
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage:
- Ethos Biosciences
- Merck
- Hardy Diagnostics
- BioMérieux
- Ricca Chemical
- Azer Scientific
- BioGnost
- Delasco
- Solarbio
- Edan Diagnostics
Key Questions Addressed in this Report:
- What is the 10-year outlook for the global Lugol's Iodine market?
- What factors are driving Lugol's Iodine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Lugol's Iodine market opportunities vary by end market size?
- How does Lugol's Iodine break out by Type, by Application?
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market